It's Skin

About It's Skin

It's Skin, a South Korean cosmeceutical company, was established on February 7, 2006, and operates under its parent company, It's Hanbul. The brand was developed through a collaboration with dermatologists from Seoul University, focusing on creating clinical solutions for a wide array of skin concerns by merging scientific research with natural ingredients. This approach targets consumers seeking effective, dermatologist-tested products to address issues ranging from dryness and aging to sensitivity and acne.

The company's business model is centered on the retail of a comprehensive range of beauty products. Its revenue is generated through the sale of skincare, makeup, and body and hair care products, distributed via its own retail stores, other retailers, and its e-commerce website. It's Skin went public and was listed on the Korea Stock Exchange on December 28, 2015. A significant milestone includes a Series A funding round on June 2, 2015, with investors like Jumei and Korea Investment Holdings.

The product portfolio is extensive, featuring lines for basic skincare, targeted treatments, and makeup. A standout offering is the Power 10 Formula Effector series, a collection of serums each targeting a specific skin issue with a designated active ingredient, such as the vitamin C-based VC Effector for blemishes or the Q10 Effector for wrinkles. Another signature product line is the Prestige D'escargot, which utilizes snail mucus for its anti-wrinkle and brightening properties. All products are dermatologist-tested to ensure safety and minimize irritation. The company's philosophy, 'Clinical + Skin = Solution', underscores its commitment to providing scientifically-backed, personalized skincare solutions based on a decade of accumulated customer skin problem data.